Clofazimine-induced interstitial lung disease with haemoptysis during therapy for Mycobacterium abscessus pulmonary disease.

We report a woman in her late 60s with a 6-month history of productive cough, low-grade fever and fatigue. Bronchoscopy yielded Mycobacterium abscessus, and she was diagnosed with M. abscessus pulmonary disease. She initially received intravenous imipenem and amikacin plus oral clarithromycin for 1 month, followed by maintenance therapy with clarithromycin and clofazimine (CFZ). One year after starting CFZ, she developed high fever, worsening cough, exertional dyspnoea and haemoptysis. Chest high-resolution CT revealed bilateral upper-lobe predominant reticular ground-glass opacities, bronchovascular and interlobular septal thickening, and focal consolidation. Bronchoscopy demonstrated reddish purple bronchoalveolar lavage fluid with brownish precipitates, and histology showed macrophages laden with crystalline material, consistent with CFZ deposition. CFZ was discontinued, leading to clinical recovery and radiographic resolution within 1 month. This case illustrates CFZ-induced lung injury presenting with haemoptysis during therapy for M. abscessus pulmonary disease. Clinicians should be aware of this rare but significant complication, particularly in patients receiving long-term CFZ.